- Home
- CELC vs IQ Comparison
CELC vs IQ Comparison
Compare CELC & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- IQ
- Stock Information
- Founded
- CELC 2011
- IQ 2009
- Country
- CELC United States
- IQ China
- Employees
- CELC N/A
- IQ N/A
- Industry
- CELC Medical Specialities
- IQ Consumer Electronics/Video Chains
- Sector
- CELC Health Care
- IQ Consumer Discretionary
- Exchange
- CELC Nasdaq
- IQ Nasdaq
- Market Cap
- CELC 2.3B
- IQ 2.4B
- IPO Year
- CELC 2017
- IQ 2018
- Fundamental
- Price
- CELC $51.88
- IQ $2.04
- Analyst Decision
- CELC Strong Buy
- IQ Strong Buy
- Analyst Count
- CELC 5
- IQ 5
- Target Price
- CELC $67.20
- IQ $2.61
- AVG Volume (30 Days)
- CELC 1.1M
- IQ 12.8M
- Earning Date
- CELC 11-13-2025
- IQ 11-20-2025
- Dividend Yield
- CELC N/A
- IQ N/A
- EPS Growth
- CELC N/A
- IQ N/A
- EPS
- CELC N/A
- IQ 0.01
- Revenue
- CELC N/A
- IQ $3,863,007,761.00
- Revenue This Year
- CELC N/A
- IQ N/A
- Revenue Next Year
- CELC N/A
- IQ $3.85
- P/E Ratio
- CELC N/A
- IQ $219.11
- Revenue Growth
- CELC N/A
- IQ N/A
- 52 Week Low
- CELC $7.58
- IQ $1.50
- 52 Week High
- CELC $63.06
- IQ $2.85
- Technical
- Relative Strength Index (RSI)
- CELC 53.91
- IQ 25.59
- Support Level
- CELC $45.15
- IQ $2.19
- Resistance Level
- CELC $50.00
- IQ $2.22
- Average True Range (ATR)
- CELC 3.48
- IQ 0.10
- MACD
- CELC -0.04
- IQ -0.07
- Stochastic Oscillator
- CELC 64.67
- IQ 6.72
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.